CONTEXT: Cognitive behavior therapy (CBT) can be effective for late-life generalized anxiety disorder (GAD), but only pilot studies have been conducted in primary care, where older adults most often seek treatment. OBJECTIVE: To examine effects of CBT relative to enhanced usual care (EUC) in older adults with GAD in primary care. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial recruiting 134 older adults (mean age, 66.9 years) from March 2004 to August 2006 in 2 primary care settings. Treatment was provided for 3 months; assessments were conducted at baseline, posttreatment (3 months), and over 12 months of follow-up, with assessments at 6, 9, 12, and 15 months. INTERVENTION: Cognitive behavior therapy (n = 70) conducted in the primary care clinics. Treatment included education and awareness, motivational interviewing, relaxation training, cognitive therapy, exposure, problem-solving skills training, and behavioral sleep management. Patients assigned to receive EUC (n = 64) received biweekly telephone calls to ensure patient safety and provide minimal support. MAIN OUTCOME MEASURES: Primary outcomes included worry severity (Penn State Worry Questionnaire) and GAD severity (GAD Severity Scale). Secondary outcomes included anxiety ratings (Hamilton Anxiety Rating Scale, Beck Anxiety Inventory), coexistent depressive symptoms (Beck Depression Inventory II), and physical/mental health quality of life (12-Item Short Form Health Survey). RESULTS:Cognitive behavior therapy compared with EUC significantly improved worry severity (45.6 [95% confidence interval {CI}, 43.4-47.8] vs 54.4 [95% CI, 51.4-57.3], respectively; P < .001), depressive symptoms (10.2 [95% CI, 8.5-11.9] vs 12.8 [95% CI, 10.5-15.1], P = .02), and general mental health (49.6 [95% CI, 47.4-51.8] vs 45.3 [95% CI, 42.6-47.9], P = .008). There was no difference in GAD severity in patients receiving CBT vs those receiving EUC (8.6 [95% CI, 7.7-9.5] vs 9.9 [95% CI, 8.7-11.1], P = .19). In intention-to-treat analyses, response rates defined according to worry severity were higher following CBT compared with EUC at 3 months (40.0% [28/70] vs 21.9% [14/64], P = .02). CONCLUSIONS: Compared with EUC, CBT resulted in greater improvement in worry severity, depressive symptoms, and general mental health for older patients with GAD in primary care. However, a measure of GAD severity did not indicate greater improvement with CBT. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00308724.
RCT Entities:
CONTEXT: Cognitive behavior therapy (CBT) can be effective for late-life generalized anxiety disorder (GAD), but only pilot studies have been conducted in primary care, where older adults most often seek treatment. OBJECTIVE: To examine effects of CBT relative to enhanced usual care (EUC) in older adults with GAD in primary care. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial recruiting 134 older adults (mean age, 66.9 years) from March 2004 to August 2006 in 2 primary care settings. Treatment was provided for 3 months; assessments were conducted at baseline, posttreatment (3 months), and over 12 months of follow-up, with assessments at 6, 9, 12, and 15 months. INTERVENTION: Cognitive behavior therapy (n = 70) conducted in the primary care clinics. Treatment included education and awareness, motivational interviewing, relaxation training, cognitive therapy, exposure, problem-solving skills training, and behavioral sleep management. Patients assigned to receive EUC (n = 64) received biweekly telephone calls to ensure patient safety and provide minimal support. MAIN OUTCOME MEASURES: Primary outcomes included worry severity (Penn State Worry Questionnaire) and GAD severity (GAD Severity Scale). Secondary outcomes included anxiety ratings (Hamilton Anxiety Rating Scale, Beck Anxiety Inventory), coexistent depressive symptoms (Beck Depression Inventory II), and physical/mental health quality of life (12-Item Short Form Health Survey). RESULTS: Cognitive behavior therapy compared with EUC significantly improved worry severity (45.6 [95% confidence interval {CI}, 43.4-47.8] vs 54.4 [95% CI, 51.4-57.3], respectively; P < .001), depressive symptoms (10.2 [95% CI, 8.5-11.9] vs 12.8 [95% CI, 10.5-15.1], P = .02), and general mental health (49.6 [95% CI, 47.4-51.8] vs 45.3 [95% CI, 42.6-47.9], P = .008). There was no difference in GAD severity in patients receiving CBT vs those receiving EUC (8.6 [95% CI, 7.7-9.5] vs 9.9 [95% CI, 8.7-11.1], P = .19). In intention-to-treat analyses, response rates defined according to worry severity were higher following CBT compared with EUC at 3 months (40.0% [28/70] vs 21.9% [14/64], P = .02). CONCLUSIONS: Compared with EUC, CBT resulted in greater improvement in worry severity, depressive symptoms, and general mental health for older patients with GAD in primary care. However, a measure of GAD severity did not indicate greater improvement with CBT. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00308724.
Authors: M K Shear; J Vander Bilt; P Rucci; J Endicott; B Lydiard; M W Otto; M H Pollack; L Chandler; J Williams; A Ali; D M Frank Journal: Depress Anxiety Date: 2001 Impact factor: 6.505
Authors: G J Hendriks; R C Oude Voshaar; G P J Keijsers; C A L Hoogduin; A J L M van Balkom Journal: Acta Psychiatr Scand Date: 2008-06 Impact factor: 6.392
Authors: Melinda A Stanley; J Gayle Beck; Diane M Novy; Patricia M Averill; Alan C Swann; Gretchen J Diefenbach; Derek R Hopko Journal: J Consult Clin Psychol Date: 2003-04
Authors: Brandon J Weiss; Jessica Calleo; Howard M Rhoades; Diane M Novy; Mark E Kunik; Eric J Lenze; Melinda A Stanley Journal: Depress Anxiety Date: 2009 Impact factor: 6.505
Authors: Jan Mohlman; Ethan E Gorenstein; Marc Kleber; Marybeth de Jesus; Jack M Gorman; Lazlo A Papp Journal: Am J Geriatr Psychiatry Date: 2003 Jan-Feb Impact factor: 4.105
Authors: Julie Loebach Wetherell; Catherine R Ayers; John T Sorrell; Steven R Thorp; Roberto Nuevo; Wendy Belding; Emily Gray; Melinda A Stanley; Patricia A Areán; Michael Donohue; Jurgen Unützer; Joe Ramsdell; Ronghui Xu; Thomas L Patterson Journal: Am J Geriatr Psychiatry Date: 2009-06 Impact factor: 4.105
Authors: Amber L Bush; Maria E A Armento; Brandon J Weiss; Howard M Rhoades; Diane M Novy; Nancy L Wilson; Mark E Kunik; Melinda A Stanley Journal: Psychiatry Res Date: 2012-04-11 Impact factor: 3.222
Authors: Cynthia Kraus-Schuman; Nancy L Wilson; Amber B Amspoker; Paula D Wagener; Jessica S Calleo; Gretchen Diefenbach; Derek Hopko; Jeffrey A Cully; Ellen Teng; Howard M Rhoades; Mark E Kunik; Melinda A Stanley Journal: Transl Behav Med Date: 2015-09 Impact factor: 3.046
Authors: Jeffrey A Cully; Melinda A Stanley; Nancy J Petersen; Natalie E Hundt; Michael R Kauth; Aanand D Naik; Kristen Sorocco; Shubhada Sansgiry; Darrell Zeno; Mark E Kunik Journal: J Gen Intern Med Date: 2017-06-20 Impact factor: 5.128
Authors: Christina M Robinson; Amber Paukert; Cynthia A Kraus-Schuman; A Lynn Snow; Mark E Kunik; Nancy L Wilson; Linda Teri; Melinda A Stanley Journal: Aging Ment Health Date: 2011-04 Impact factor: 3.658
Authors: Srijana Shrestha; Melinda A Stanley; Nancy L Wilson; Jeffrey A Cully; Mark E Kunik; Diane M Novy; Howard M Rhoades; Amber B Amspoker Journal: Int Psychogeriatr Date: 2014-12-12 Impact factor: 3.878
Authors: Jessica S Calleo; Amber L Bush; Jeffrey A Cully; Nancy L Wilson; Cynthia Kraus-Schuman; Howard M Rhoades; Diane M Novy; Nicholas Masozera; Susan Williams; Matthew Horsfield; Mark E Kunik; Melinda A Stanley Journal: J Nerv Ment Dis Date: 2013-05 Impact factor: 2.254
Authors: Julie Loebach Wetherell; Andrew J Petkus; Steven R Thorp; Murray B Stein; Denise A Chavira; Laura Campbell-Sills; Michelle G Craske; Cathy Sherbourne; Alexander Bystritsky; Greer Sullivan; Peter Roy-Byrne Journal: Br J Psychiatry Date: 2013-04-11 Impact factor: 9.319